WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first ...

The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...

safety and ease of administration of the rapid-acting insulin analogue insulin aspart in comparison with human insulin (HI) in diabetes mellitus in the following categories: (a) in adults ...

and Fiasp (insulin aspart), by more than 70% starting Jan. 1, 2026. Fiasp's price will be reduced by 75%, making it the same ...

an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart. Sanofi-Aventis' Merilog version of the product has been cleared for the treatment of adult and ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on ...

Rapid-acting insulin called insulin aspart - this lowers your blood sugar level soon after you inject it. Ryzodeg ® 70/30 is a modified insulin, also called an insulin analogue, which is similar ...

Rapid acting insulin called insulin aspart - this lowers your blood sugar soon after you inject it. Ryzodeg ® 70/30 is a modified insulin, also called an insulin analogue, which is similar to the ...

Find all the commercial and brand names of generic drug called Insulin Aspart. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Potential Weakness: The potential weakness of the studies is that they were of relatively short duration (≤24 weeks) and so the long-term effects of insulin aspart in CSII cannot be assessed.